Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Letermovir Resistance Analysis in a Clinical Trial of Cytomegalovirus Prophylaxis for Hematopoietic Stem Cell Transplant Recipients
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-11-15
DOI
10.1093/infdis/jiz577
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Letermovir as Salvage Therapy for Drug-resistant CMV Retinitis: A Case Series
- (2019) Nicholas Turner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation
- (2019) Jochen J Frietsch et al. Mediterranean Journal of Hematology and Infectious Diseases
- A New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by in vitro Exposure to Letermovir and Ganciclovir
- (2018) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection
- (2018) Lauren Cherrier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Targeting the terminase: An important step forward in the treatment and prophylaxis of human cytomegalovirus infections
- (2018) Brian G. Gentry et al. ANTIVIRAL RESEARCH
- Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis
- (2018) Bettina M. Knoll et al. BONE MARROW TRANSPLANTATION
- Differentiated Levels of Ganciclovir Resistance Conferred by Mutations at Codons 591 to 603 of the Cytomegalovirus UL97 Kinase Gene
- (2017) Sunwen Chou et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
- (2017) Francisco M. Marty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of glycoprotein B genotype and naturally occurring ORF UL56 polymorphisms upon susceptibility of clinical human cytomegalovirus isolates to letermovir
- (2016) Peter Lischka et al. ANTIVIRAL RESEARCH
- RapidIn VitroEvolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
- (2015) Sunwen Chou ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)
- (2015) Peter Lischka et al. JOURNAL OF INFECTIOUS DISEASES
- Improved Detection of Emerging Drug-Resistant Mutant Cytomegalovirus Subpopulations by Deep Sequencing
- (2014) Sunwen Chou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism
- (2014) Léa Pilorgé et al. ANTIVIRAL RESEARCH
- Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
- (2014) Roy F. Chemaly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure
- (2013) Thomas Goldner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Detection of Cytomegalovirus Drug Resistance Mutations by Next-Generation Sequencing
- (2013) Malaya K. Sahoo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
- (2011) Per Ljungman et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
- (2011) T. Goldner et al. JOURNAL OF VIROLOGY
- In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
- (2010) P. Lischka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation